Concepedia

Author

Jennifer D. Hintzsche

University of Colorado DenverORCID

Also Known As

Hintzsche, Jennifer Diane, Hintzsche, Jennifer Diane., Jennifer D. Hintzsche, Jennifer Hintzsche

46

Publications

897

Citations

8

H-Index

28

Concepts

All Affiliations

University of Colorado DenverUniversity of Colorado Anschutz Medical CampusUniversity of Colorado Cancer CenterMoffitt Cancer CenterColorado School of Public Health
JD

About

Jennifer D. Hintzsche is an author at University of Colorado Denver specializing in medicine, plant genomics, and plant genetics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

560

2

Natural Sciences

1

1

383

3

Biology

1

1

383

4

Molecular Genetics

1

1

383

5

Pathology

1

1

177

Jennifer D. Hintzsche

×

7

Publications

810

Citations

7

H-Index

YearCitations

Insight into the evolution of the Solanaceae from the parental genomes of Petunia hybrida

Aureliano Bombarely, Michel Moser, Avichai Amrad,

Nature Plants

2016

383

Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma

Jennifer D. Hintzsche, Nicholas T. Gorden, Carol M. Amato,

Melanoma Research

2017

177

Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy

Carol M. Amato, Jennifer D. Hintzsche, Keith Wells,

Cancers

2020

74

Kinase gene fusions in defined subsets of melanoma

Jacqueline A. Turner, Kasey L. Couts, Jamie Sheren,

Pigment Cell & Melanoma Research

2016

55

ALK Inhibitor Response in Melanomas Expressing <i>EML4-ALK</i> Fusions and Alternate <i>ALK</i> Isoforms

Kasey L. Couts, Judson Bemis, Jacqueline A. Turner,

Molecular Cancer Therapeutics

2017

46

IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples

Jennifer D. Hintzsche, Jihye Kim, Vinod Kumar Yadav,

Journal of the American Medical Informatics Association

2016

40

Targeting CDK4/6 Represents a Therapeutic Vulnerability in Acquired BRAF/MEK Inhibitor–Resistant Melanoma

Kelsey W. Nassar, Jennifer D. Hintzsche, Stacey M. Bagby,

Molecular Cancer Therapeutics

2021

35

Page 1